Private Label Tranexamic Acid Body Wash Manufacturer Low MOQ

Is tranexamic acid safe in a body wash and are there any regulatory restrictions?

By Blake Mereby · Last reviewed September 30, 2026

Tranexamic acid is considered safe for cosmetic use in a body wash format when used at concentrations up to approximately 3% in rinse-off products, based on the available safety data and the assessments of major regulatory bodies. There is no global ban or specific restriction on TXA in cosmetics as of 2024.

In the United States, the FDA does not have a specific approved list for cosmetic ingredients the way it does for food additives or drug actives. Cosmetic safety is the responsibility of the manufacturer and brand owner under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Tranexamic acid is used at cosmetic concentrations and, in a rinse-off format, does not penetrate skin sufficiently to trigger drug-classification concerns. It is not on the FDA's list of prohibited or restricted cosmetic ingredients. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) tightened safety substantiation requirements for cosmetic brands, so your manufacturer should provide you with a safety substantiation package regardless.

In the European Union, cosmetic ingredients are governed by Regulation (EC) No 1223/2009. Tranexamic acid does not appear in Annex II (prohibited substances) or Annex III (restricted substances) as of the most recent updates, meaning it may be used at cosmetically appropriate concentrations. However, EU law requires a Cosmetic Safety Assessment (Annex I Part B) signed by a qualified cosmetic safety assessor before any product is placed on the EU market. That assessor will evaluate TXA concentration, skin penetration data, and rinse-off exposure in their risk assessment.

In Japan, tranexamic acid occupies an unusual dual status: it is approved as a quasi-drug (医薬部外品) brightening active at concentrations up to 2%, meaning products making brightening claims with TXA may be classified as quasi-drugs and require pre-market approval. If you intend to sell in Japan, consult a regulatory specialist before launch.

In South Korea, TXA is permitted in cosmetics and widely used in K-beauty brightening products. No special restrictions apply for rinse-off formats.

For a US-only launch, the practical regulatory steps are: complete INCI labeling, substantiate your claims as cosmetic (not drug) claims, file voluntarily with FDA's VCRP, and retain a safety dossier. For EU or multi-market launches, budget for a qualified safety assessor and CPNP notification.

The common first-timer mistake is making drug-adjacent claims like "treats hyperpigmentation" or "clinically proven to eliminate dark spots" — language that can pull a cosmetic body wash into OTC drug territory in the US or trigger regulatory scrutiny in the EU. Stick to cosmetic claim language: "helps visibly even skin tone," "brightening body wash," "reduces the appearance of uneven pigmentation."

Ingredients in this answer: Tranexamic Acid

Read the full guide on Private Label Tranexamic Acid Body Wash Manufacturer Low MOQ →

More about Private Label Tranexamic Acid Body Wash Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app